Physician profile
Earl D Cottrell
NPI 1194804211
$29,692.41
in general payments reported to CMS, 2019-2025
10 companies · $1,615 in 2025
The $1,615 reported for 2025 was more than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $10K · 2020: $6,627 · 2021: $6,326 · 2022: $1,600 · 2023: $1,615 · 2024: $1,720 · 2025: $1,615.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $4,800 · Food and Beverage: $150.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $4,800.00 |
| Food and Beverage | $149.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Centinel Spine, LLC | $15,613.17 | 2019-2021 | |
| Angiodynamics, INC. | $13,600.00 | 2019-2025 | Venacure 1470 Pro |
| Nuvasive, INC. | $176.28 | 2019 | |
| Tactile Systems Technology INC | $134.42 | 2019-2025 | Flexitouch Plus, Entre Plus, Nimbl |
| Endologix LLC | $50.55 | 2024 | Endocross Device, Torus Stent Graft System |
| Biom'Up France Sas | $44.73 | 2020 | |
| Lemaitre Vascular, INC. | $20.95 | 2024 | Anastoclip Gc 8cm (Medium) |
| Janssen Pharmaceuticals, INC | $20.27 | 2019 | |
| Biom'Up Sa | $17.44 | 2019 | |
| Boston Scientific Corporation | $14.60 | 2023 | Varithena Administration Pack |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Earl Cottrell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.